Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (341-350 of 494) with videos related to

Pageof 50
Sort By:
Plos Pathogens|April 7, 2023
A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infectionMylene Vaillancourt, Anna Clara Milesi Galdino, Sam P Limsuwannarot, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2024
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in JapanRyota Hase, Aki Sakurai, Masahiro Suzuki, et al.
Molecular Therapy. Nucleic Acids|August 11, 2022
A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in <i>M</i>. <i>tuberculosis</i>Siyuan Feng, Lujie Liang, Cong Shen, et al.
Mbio|April 8, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocolAkito Kawai, Christi L McElheny, Ryan K Shields, et al.
European Journal of Medicinal Chemistry|June 5, 2026
IMD-0354 optimization generates potent colistin adjuvants with in vivo activity and reduced eukaryotic toxicityLuke J Cowart, Ansley M Nemeth, Leigh A Jania, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2016
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne <i>bla</i><sub>KPC-3</sub> Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae InfectionsRyan K Shields, Liang Chen, Shaoji Cheng, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
<i>In Vitro</i> Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Kazuhiro Ishikawa, Yuki Uehara, Nobuyoshi Mori, et al.
Influenza and Other Respiratory Viruses|June 18, 2024
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical TrialNorio Ohmagari, Hiroshi Yotsuyanagi, Yohei Doi, et al.
JAMA Network Open|February 9, 2024
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical TrialHiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Infection Control and Hospital Epidemiology|December 8, 2016
Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Citrobacter freundii at a Tertiary Acute Care Facility in Miami, FloridaAdriana Jiménez, José G Castro, L Silvia Munoz-Price, et al.
Pageof 50

Showing results (341-350 of 494) with videos related to

Sort By:
Pageof 50
Plos Pathogens|April 7, 2023
A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infectionMylene Vaillancourt, Anna Clara Milesi Galdino, Sam P Limsuwannarot, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2024
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in JapanRyota Hase, Aki Sakurai, Masahiro Suzuki, et al.
Molecular Therapy. Nucleic Acids|August 11, 2022
A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in <i>M</i>. <i>tuberculosis</i>Siyuan Feng, Lujie Liang, Cong Shen, et al.
Mbio|April 8, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocolAkito Kawai, Christi L McElheny, Ryan K Shields, et al.
European Journal of Medicinal Chemistry|June 5, 2026
IMD-0354 optimization generates potent colistin adjuvants with in vivo activity and reduced eukaryotic toxicityLuke J Cowart, Ansley M Nemeth, Leigh A Jania, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2016
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne <i>bla</i><sub>KPC-3</sub> Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae InfectionsRyan K Shields, Liang Chen, Shaoji Cheng, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
<i>In Vitro</i> Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Kazuhiro Ishikawa, Yuki Uehara, Nobuyoshi Mori, et al.
Influenza and Other Respiratory Viruses|June 18, 2024
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical TrialNorio Ohmagari, Hiroshi Yotsuyanagi, Yohei Doi, et al.
JAMA Network Open|February 9, 2024
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical TrialHiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Infection Control and Hospital Epidemiology|December 8, 2016
Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Citrobacter freundii at a Tertiary Acute Care Facility in Miami, FloridaAdriana Jiménez, José G Castro, L Silvia Munoz-Price, et al.
Pageof 50